Antibiotic use and misuse during pregnancy and delivery: Benefits and risks

International Journal of Environmental Research and Public Health

Volumn 11, Issue 8, 2014, Pages 7993-8009

  de Tejada, Begoña Martinez ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Antibiotics; Fetal; Infant; Morbidity; Neonatal; Pregnancy; Risk

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; METRONIDAZOLE; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; HEALTH RISK; MORBIDITY; PREGNANCY;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CEREBRAL PALSY; CESAREAN SECTION; CHLAMYDIASIS; CHORIOAMNIONITIS; DELIVERY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG INDICATION; DRUG MISUSE; DRUG USE; FEVER; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INTRAPARTUM FEVER; MATERNAL MORBIDITY; NEWBORN DISEASE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL EXPOSURE; PRESCRIPTION; PUERPERAL INFECTION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SYPHILIS; TRICHOMONIASIS; URINARY TRACT INFECTION; VERTICAL TRANSMISSION; FEMALE;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; PREGNANCY; RISK ASSESSMENT;

EID: 84907259761     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110807993     Document Type: Review

References (119)

1. Nahum, G.G.; Uhl, K.; Kennedy, D.L. Antibiotic use in pregnancy and lactation: What is and is not known about teratogenic and toxic risks. Obstet. Gynecol. 2006, 107, 1120-1138.
2. Ledger, W.J.; Blaser, M.J. Are we using too many antibiotics during pregnancy? BJOG 2013, 120, 1450-1452.
3. Verani, J.R.; McGee, L.; Schrag, S.J. Prevention of perinatal group B streptococcal disease-Revised guidelines from CDC, 2010. MMWR Recomm. Rep. 2010, 59, 1-36.
4. Macones, G.A.; Cleary, K.L.; Parry, S.; Stamilio, D.M.; Cahill, A.G.; Odibo, A.O.; Rampersad, R. The timing of antibiotics at cesarean: A randomized controlled trial. Amer. J. Perinatol. 2012, 29, 273-276.
5. Goldenberg, R.L.; Culhane, J.F.; Iams, J.D.; Romero, R. Epidemiology and causes of preterm birth. Lancet 2008, 371, 75-84.
6. Marcos, Z. Arriving too early. Lancet Neurol. 2013, 12, 332-333.
7. Lawn, J.E.; Kinney, M.V.; Belizan, J.M.; Mason, E.M.; McDougall, L.; Larson, J.; Lackritz, E.; Friberg, I.K.; Howson, C.P. Born too soon: Accelerating actions for prevention and care of 15 million newborns born too soon. Reprod. Health 2013, 10, doi:10.1186/1742-4755-10-S1-S6.
8. Chang, H.H.; Larson, J.; Blencowe, H.; Spong, C.Y.; Howson, C.P.; Cairns-Smith, S.; Lackritz, E.M.; Lee, S.K.; Mason, E.; Serazin, A.C.; et al. Preventing preterm births: Analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 2013, 381, 223-234.
9. Mercer, B.M. Preterm premature rupture of the membranes. Obstet. Gynecol. 2003, 101, 178-193.
10. Soilly, A.L.; Lejeune, C.; Quantin, C.; Bejean, S.; Gouyon, J.B. Economic analysis of the costs associated with prematurity from a literature review. Public Health 2014, 128, 43-62.
11. Gilbert, W.M.; Nesbitt, T.S.; Danielsen, B. The cost of prematurity: Quantification by gestational age and birth weight. Obstet. Gynecol. 2003, 102, 488-492.
12. Takayama, J.I.; Matsuo, N. The enigma of spontaneous preterm birth. N. Engl. J. Med. 2010, 362, 2032-2033.
13. Pararas, M.V.; Skevaki, C.L.; Kafetzis, D.A. Preterm birth due to maternal infection: Causative pathogens and modes of prevention. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25, 562-569.
14. Gravett, M.G.; Novy, M.J.; Rosenfeld, R.G.; Reddy, A.P.; Jacob, T.; Turner, M.; McCormack, A.; Lapidus, J.A.; Hitti, J.; Eschenbach, D.A.; et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004, 292, 462-469.
15. Burdet, J.; Rubio, A.P.; Salazar, A.I.; Ribeiro, M.L.; Ibarra, C.; Franchi, A.M. Inflammation, infection and preterm birth. Curr. Pharm. Des. 2014, doi:10.2174/1381612820666140130202224.
16. Farina, L.; Winkelman, C. A review of the role of proinflammatory cytokines in labor and noninfectious preterm labor. Biol. Res. Nurs. 2005, 6, 230-238.
17. Wei, S.Q.; Fraser, W.; Luo, Z.C. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: A systematic review. Obstet. Gynecol. 2010, 116, 393-401.
18. Lyon, D.; Cheng, C.Y.; Howland, L.; Rattican, D.; Jallo, N.; Pickler, R.; Brown, L.; McGrath, J. Integrated review of cytokines in maternal, cord, and newborn blood: Part I-Associations with preterm birth. Biol. Res. Nurs. 2010, 11, 371-376.
19. Murtha, A.P.; Greig, P.C.; Jimmerson, C.E.; Herbert, W.N. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet. Gynecol. 1998, 91, 161-164.
20. Torbe, A.; Czajka, R.; Kordek, A.; Rzepka, R.; Kwiatkowski, S.; Rudnicki, J. Maternal serum proinflammatory cytokines in preterm labor with intact membranes: Neonatal outcome and histological associations. Eur. Cytokine Netw. 2007, 18, 102-107.
21. Vogel, I.; Goepfert, A.R.; Thorsen, P.; Skogstrand, K.; Hougaard, D.M.; Curry, A.H.; Cliver, S.; Andrews, W.W. Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth. J. Reprod. Immunol. 2007, 75, 133-140.
22. Von Minckwitz, G.; Grischke, E.M.; Schwab, S.; Hettinger, S.; Loibl, S.; Aulmann, M.; Kaufmann, M. Predictive value of serum interleukin-6 and-8 levels in preterm labor or rupture of the membranes. Acta Obstet. Gynecol. Scand. 2000, 79, 667-672.
23. Lamont, R.F.; Nhan-Chang, C.L.; Sobel, J.D.; Workowski, K.; Conde-Agudelo, A.; Romero, R. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: A systematic review and metaanalysis. Amer. J. Obstet. Gynecol. 2011, 205, 177-190.
24. Kenyon, S.L.; Taylor, D.J.; Tarnow-Mordi, W. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001, 357, 989-994.
25. Flenady, V.; Hawley, G.; Stock, O.M.; Kenyon, S.; Badawi, N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst. Rev. 2013, 12, doi:10.1002/14651858.CD000246.
26. Kenyon, S.; Pike, K.; Jones, D.R.; Brocklehurst, P.; Marlow, N.; Salt, A.; Taylor, D.J. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008, 372, 1319-1327.
27. Kenyon, S.L.; Taylor, D.J.; Tarnow-Mordi, W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: The ORACLE I randomised trial. Lancet 2001, 357, 979-988.
28. Kenyon, S.; Boulvain, M.; Neilson, J.P. Antibiotics for preterm rupture of membranes. Cochrane Database Syst. Rev. 2013, 12, doi:10.1002/14651858.CD001058.
29. Brocklehurst, P.; Gordon, A.; Heatley, E.; Milan, S.J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. 2013, 1, doi:10.1002/14651858.CD000262.pub4.
30. Cunnington, M.; Kortsalioudaki, C.; Heath, P. Genitourinary pathogens and preterm birth. Curr. Opin. Infect. Dis. 2013, 26, 219-230.
31. Uncu, Y.; Uncu, G.; Esmer, A.; Bilgel, N. Should asymptomatic bacteriuria be screened in pregnancy? Clin. Exp. Obstet. Gynecol. 2002, 29, 281-285.
32. Carey, J.C.; Klebanoff, M.A.; Hauth, J.C.; Hillier, S.L.; Thom, E.A.; Ernest, J.M.; Heine, R.P.; Nugent, R.P.; Fischer, M.L.; Leveno, K.J.; et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N. Engl. J. Med. 2000, 342, 534-540.
33. Klebanoff, M.A.; Hillier, S.L.; Nugent, R.P.; MacPherson, C.A.; Hauth, J.C.; Carey, J.C.; Harper, M.; Wapner, R.J.; Trout, W.; Moawad, A.; et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Amer. J. Obstet. Gynecol. 2005, 192, 470-477.
34. Okun, N.; Gronau, K.A.; Hannah, M.E. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: A systematic review. Obstet. Gynecol. 2005, 105, 857-868.
35. Oliver, R.S.; Lamont, R.F. Infection and antibiotics in the aetiology, prediction and prevention of preterm birth. J. Obstet. Gynaecol. 2013, 33, 768-775.
36. Subtil, D.; Brabant, G.; Tilloy, E.; Salleron, J.; Canis, F.; Fruchart, A.; Bissinger, M.-C.; Dugimont, J.-C.; Catherine, N.; Chantrel, J.; et al. Early clindamycin for bacterial vaginosis in low-risk pregnancy: The PREMEVA1 randomized, multicenter, double-blind, placebo-controlled trial. Amer. J. Obstet. Gynecol. 2014, 210, S3.
37. Mercer, B.M.; Goldenberg, R.L.; Das, A.F.; Thurnau, G.R.; Bendon, R.W.; Miodovnik, M.; Ramsey, R.D.; Rabello, Y.A.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin. Perinatol. 2003, 27, 217-230.
38. Adriaanse, A.H.; Lagendijk, I.; Muytjens, H.L.; Nijhuis, J.G.; Kollee, L.-A. Neonatal early onset group B streptococcal infection. A nine-year retrospective study in a tertiary care hospital. J. Perinat. Med. 1996, 24, 531-538.
39. Allardice, J.G.; Baskett, T.F.; Seshia, M.M.; Bowman, N.; Malazdrewicz, R. Perinatal group B streptococcal colonization and infection. Amer. J. Obstet. Gynecol. 1982, 142, 617-620.
40. Baltimore, R.S.; Huie, S.M.; Meek, J.I.; Schuchat, A.; O'Brien, K.L. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001, 108, 1094-1098.
41. Van Dyke, M.K.; Phares, C.R.; Lynfield, R.; Thomas, A.R.; Arnold, K.E.; Craig, A.S.; Mohle-Boetani, J.; Gershman, K.; Schaffner, W.; Petit, S.; et al. Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 2009, 360, 2626-2636.
42. Lukacs, S.L.; Schrag, S.J. Clinical sepsis in neonates and young infants, United States, 1988-2006. J. Pediatr. 2012, 160, 960-965.
43. Heath, P.T.; Balfour, G.; Weisner, A.M.; Efstratiou, A.; Lamagni, T.L.; Tighe, H.; O'Connell, L.A.; Cafferkey, M.; Verlander, N.Q.; Nicoll, A.; et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004, 363, 292-294.
44. Easmon, C.S. The carrier state: Group B streptococcus. J. Antimicrob. Chemother. 1986, 18, S59-S65.
45. El Helali, N.; Nguyen, J.C.; Ly, A.; Giovangrandi, Y.; Trinquart, L. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin. Infect. Dis. 2009, 49, 417-423.
46. Edwards, R.K.; Clark, P.; Duff, P. Intrapartum antibiotic prophylaxis 2: Positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet. Gynecol. 2002, 100, 540-544.
47. Stan, C.M.; Boulvain, M.; Bovier, P.A.; Auckenthaler, R.; Berner, M.; Irion, O. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: Economic evaluation. BJOG 2001, 108, 840-847.
48. Towers, C.V.; Rumney, P.J.; Asrat, T.; Preslicka, C.; Ghamsary, M.G.; Nageotte, M.P. The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery. Amer. J. Perinatol. 2010, 27, 785-790.
49. Puopolo, K.M.; Madoff, L.C.; Eichenwald, E.C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005, 115, 1240-1246.
50. Antenatal Care. NICE Clinical Guideline. Available online: http://www.nice.org.uk/guidance/CG62 (accessed on 5 August 2014).
51. Royal College of Obstetricians and Gynaecologists. The prevention of early-onset neonatal group b streptococcal disease. Green-top Guidel. 2012, 36, 1-13.
52. Lyytikainen, O.; Nuorti, J.P.; Halmesmaki, E.; Carlson, P.; Uotila, J.; Vuento, R.; Ranta, T.; Sarkkinen, H.; Ammala, M.; Kostiala, A.; et al. Invasive group B streptococcal infections in Finland: A population-based study. Emerg. Infect. Dis. 2003, 9, 469-473.
53. Martinelli, P.; Sarno, L.; Maruotti, G.M.; Paludetto, R. Chorioamnionitis and prematurity: A critical review. J. Matern. Fetal Neonatal Med. 2012, 25, S29-S31.
54. Shatrov, J.G.; Birch, S.C.; Lam, L.T.; Quinlivan, J.A.; McIntyre, S.; Mendz, G.L. Chorioamnionitis and cerebral palsy: A meta-analysis. Obstet. Gynecol. 2010, 116, 387-392.
55. Wu, Y.W.; Colford, J.M., Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000, 284, 1417-1424.
56. Been, J.V.; Lievense, S.; Zimmermann, L.J.; Kramer, B.W.; Wolfs, T.G. Chorioamnionitis as a risk factor for necrotizing enterocolitis: A systematic review and meta-analysis. J. Pediatr. 2013, 162, 236-242.
57. Gibbs, R.S.; Dinsmoor, M.J.; Newton, E.R.; Ramamurthy, R.S. A randomized trial of intrapartum vs. immediate postpartum treatment of women with intra-amniotic infection. Obstet. Gynecol. 1988, 72, 823-828.
58. Sperling, R.S.; Ramamurthy, R.S.; Gibbs, R.S. A comparison of intrapartum vs. immediate postpartum treatment of intra-amniotic infection. Obstet. Gynecol. 1987, 70, 861-865.
59. Hirsch, H.A.; Niehues, U. Maternal morbidity following cesarean section: Effect of infection control and preventive use of antibiotics. Geburtshilfe Frauenheilkd. 1988, 48, 1-7.
60. Lamont, R.F.; Sobel, J.D.; Kusanovic, J.P.; Vaisbuch, E.; Mazaki-Tovi, S.; Kim, S.K.; Uldbjerg, N.; Romero, R. Current debate on the use of antibiotic prophylaxis for caesarean section. BJOG 2011, 118, 193-201.
61. Wallace, R.L.; Yonekura, M.L. The use of prophylactic antibiotics in patients undergoing emergency primary cesarean section. Amer. J. Obstet. Gynecol. 1983, 147, 533-536.
62. Apuzzio, J.J.; Reyelt, C.; Pelosi, M.; Sen, P.; Louria, D.B. Prophylactic antibiotics for cesarean section: Comparison of high-and low-risk patients for endomyometritis. Obstet. Gynecol. 1982, 59, 693-698.
63. Chelmow, D.; Hennesy, M.; Evantash, E.G. Prophylactic antibiotics for non-laboring patients with intact membranes undergoing cesarean delivery: An economic analysis. Amer. J. Obstet. Gynecol. 2004, 191, 1661-1665.
64. Smaill, F.M.; Gyte, G.M. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst. Rev. 2010, doi:10.1002/14651858.CD007482.pub2.
65. Costantine, M.M.; Rahman, M.; Ghulmiyah, L.; Byers, B.D.; Longo, M.; Wen, T.; Hankins, G.D.; Saade, G.R. Timing of perioperative antibiotics for cesarean delivery: A metaanalysis. Amer. J. Obstet. Gynecol. 2008, 199, doi:10.1016/j.ajog.2008.06.077.
66. Rosenberg, K. Preprocedure antibiotics reduce infection after cesarean delivery. Amer. J. Nurs. 2012, 112, doi:10.1097/01.NAJ.0000422237.25309.8b.
67. Sun, J.; Ding, M.; Liu, J.; Li, Y.; Sun, X.; Liu, T.; Chen, Y.; Liu, J. Prophylactic administration of cefazolin prior to skin incision vs. antibiotics at cord clamping in preventing postcesarean infectious morbidity: A systematic review and meta-analysis of randomized controlled trials. Gynecol. Obstet. Investig. 2013, 75, 175-178.
68. Francis, C.; Mumford, M.; Strand, M.L.; Moore, E.S.; Strand, E.A. Timing of prophylactic antibiotic at cesarean section: A double-blinded, randomized trial. J. Perinatol. 2013, 33, 759-762.
69. Witt, A.; Doner, M.; Petricevic, L.; Berger, A.; Germann, P.; Heinze, G.; Tempfer, C. Antibiotic prophylaxis before surgery vs. after cord clamping in elective cesarean delivery: A double-blind, prospective, randomized, placebo-controlled trial. Arch. Surg. 2011, 146, 1404-1409.
70. Yildirim, G.; Gungorduk, K.; Guven, H.Z.; Aslan, H.; Celikkol, O.; Sudolmus, S.; Ceylan, Y. When should we perform prophylactic antibiotics in elective cesarean cases? Arch. Gynecol. Obstet. 2009, 280, 13-18.
71. Capitulo, K.L.; Klein, V.R.; Wright, M. Should prophylactic antibiotics be routinely given to a mother before a cesarean birth? Amer. J. Matern. Child. Nurs. 2013, 38, 266-267.
72. Rao, G.A.; Mann, J.R.; Shoaibi, A.; Bennett, C.L.; Nahhas, G.; Sutton, S.S.; Jacob, S.; Strayer, S.M. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann. Fam. Med. 2014, 12, 121-127.
73. Morales, W.J.; Dickey, S.S.; Bornick, P.; Lim, D.V. Change in antibiotic resistance of group B streptococcus: Impact on intrapartum management. Amer. J. Obstet. Gynecol. 1999, 181, 310-314.
74. Heelan, J.S.; Hasenbein, M.E.; McAdam, A.J. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J. Clin. Microbiol. 2004, 42, 1263-1264.
75. Borahay, M.A.; Harirah, H.M.; Olson, G.; Kilic, G.S.; Karipcin, S.; Hankins, G.D. Disseminated intravascular coagulation, hemoperitoneum, and reversible ischemic neurological deficit complicating anaphylaxis to prophylactic antibiotics during cesarean delivery: A case report and review of literature. AJP Rep. 2011, 1, 15-20.
76. Sengupta, A.; Kohli, J.-K. Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death. J. Obstet. Gynaecol. Res. 2008, 34, 252-254.
77. Mulla, Z.D.; Ebrahim, M.S.; Gonzalez, J.L. Anaphylaxis in the obstetric patient: Analysis of a statewide hospital discharge database. Ann. Allergy Asthma Immunol. 2010, 104, 55-59.
78. Berenguer, A.; Couto, A.; Brites, V.; Fernandes, R. Anaphylaxis in pregnancy: A rare cause of neonatal mortality. BMJ Case Rep. 2013, 2013, doi:10.1136/bcr-2012-007055.
79. Simons, F.E.; Schatz, M. Anaphylaxis during pregnancy. J. Allergy Clin. Immunol. 2012, 130, 597-606.
80. Jakobsson, H.E.; Jernberg, C.; Andersson, A.F.; Sjolund-Karlsson, M.; Jansson, J.K.; Engstrand, L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010, 5, doi:10.1371/journal.pone.0009836.
81. Bedford Russell, A.R.; Murch, S.H. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006, 113, 758-765.
82. Bizzarro, M.J.; Dembry, L.M.; Baltimore, R.S.; Gallagher, P.G. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008, 121, 689-696.
83. Martino, D.J.; Prescott, S.L. Silent mysteries: Epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 2010, 65, 7-15.
84. Jedrychowski, W.; Galas, A.; Whyatt, R.; Perera, F. The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study. Int. J. Occup. Med. Environ. Health 2006, 19, 70-76.
85. Flohr, C.; Yeo, L. Atopic dermatitis and the hygiene hypothesis revisited. Curr. Probl. Dermatol. 2011, 41, 1-34.
86. Adlerberth, I.; Lindberg, E.; Aberg, N.; Hesselmar, B.; Saalman, R.; Strannegard, I.L.; Wold, A.E. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: An effect of hygienic lifestyle? Pediatr. Res. 2006, 59, 96-101.
87. Murk, W.; Risnes, K.R.; Bracken, M.B. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: A systematic review. Pediatrics 2011, 127, 1125-1138.
88. Jensen, E.T.; Kappelman, M.D.; Kim, H.P.; Ringel-Kulka, T.; Dellon, E.S. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 2013, 57, 67-71.
89. Risnes, K.R.; Belanger, K.; Murk, W.; Bracken, M.B. Antibiotic exposure by 6 months and asthma and allergy at 6 years: Findings in a cohort of 1401 U.S. children. Amer. J. Epidemiol. 2011, 173, 310-318.
90. Metsala, J.; Lundqvist, A.; Virta, L.J.; Kaila, M.; Gissler, M.; Virtanen, S.M. Mother's and offspring's use of antibiotics and infant allergy to cow's milk. Epidemiology 2013, 24, 303-309.
91. Martel, M.J.; Rey, E.; Malo, J.L.; Perreault, S.; Beauchesne, M.F.; Forget, A.; Blais, L. Determinants of the incidence of childhood asthma: A two-stage case-control study. Amer. J. Epidemiol. 2009, 169, 195-205.
92. Benjamin, D.K., Jr.; Stoll, B.J.; Gantz, M.G.; Walsh, M.C.; Sanchez, P.J.; Das, A.; Shankaran, S.; Higgins, R.D.; Auten, K.J.; Miller, N.A.; et al. Neonatal candidiasis: Epidemiology, risk factors, and clinical judgment. Pediatrics 2010, 126, 865-873.
93. Kozyrskyj, A.L.; Bahreinian, S.; Azad, M.B. Early life exposures: Impact on asthma and allergic disease. Curr. Opin. Allergy Clin. Immunol. 2011, 11, 400-406.
94. Tan, S.; Holliman, R.; Russell, A.R. Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes. Lancet 2003, 361, doi:10.1016/S0140-6736(03)12420-8.
95. Gygax, S.E.; Schuyler, J.A.; Trama, J.P.; Mordechai, E.; Adelson, M.E. Detection of erythromycin and clindamycin resistance genes in Group B Streptococcal clinical isolates and cervicovaginal-rectal swabs. Microb. Drug Resist. 2007, 13, 119-123.
96. Edwards, R.K.; Jamie, W.E.; Sterner, D.; Gentry, S.; Counts, K.; Duff, P. Intrapartum antibiotic prophylaxis and early-onset neonatal sepsis patterns. Infect. Dis. Obstet. Gynecol. 2003, 11, 221-226.
97. Towers, C.V.; Carr, M.H.; Padilla, G.; Asrat, T. Potential consequences of widespread antepartal use of ampicillin. Amer. J. Obstet. Gynecol. 1998, 179, 879-883.
98. Chelmow, D.; Ruehli, M.S.; Huang, E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: A meta-analysis. Amer. J. Obstet. Gynecol. 2001, 184, 656-661.
99. Fredriksson, A.; Thomassen, P. Preventive antibiotics in emergency cesarean section. A prospective comparison of benzylpenicillin and ampicillin plus cloxacillin. Tidsskr. Nor. Laegeforen. 1990, 110, 348-350.
100. Bergeron, M.G.; Ke, D.; Menard, C.; Picard, F.J.; Gagnon, M.; Bernier, M.; Ouellette, M.; Roy, P.H.; Marcoux, S.; Fraser, W.D. Rapid detection of group B streptococci in pregnant women at delivery. N. Engl. J. Med. 2000, 343, 175-179.
101. Edwards, R.K.; Novak-Weekley, S.M.; Koty, P.P.; Davis, T.; Leeds, L.J.; Jordan, J.A. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet. Gynecol. 2008, 111, 1335-1341.
102. De Tejada, B.M.; Pfister, R.E.; Renzi, G.; Francois, P.; Irion, O.; Boulvain, M.; Schrenzel, J. Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin. Microbiol. Infect. 2011, 17, 1786-1791.
103. Daniels, J.P.; Gray, J.; Pattison, H.M.; Gray, R.; Hills, R.K.; Khan, K.S. Intrapartum tests for group B streptococcus: Accuracy and acceptability of screening. BJOG 2011, 118, 257-265.
104. Davies, H.D.; Miller, M.A.; Faro, S.; Gregson, D.; Kehl, S.C.; Jordan, J.A. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin. Infect. Dis. 2004, 39, 1129-1135.
105. Gavino, M.; Wang, E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Amer. J. Obstet. Gynecol. 2007, 197, 1-4.
106. El Helali, N.; Giovangrandi, Y.; Guyot, K.; Chevet, K.; Gutmann, L.; Durand-Zaleski, I. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet. Gynecol. 2012, 119, 822-829.
107. Kenyon, S.; Taylor, D.J.; Tarnow-Mordi, W.O. ORACLE-Antibiotics for preterm prelabour rupture of the membranes: Short-term and long-term outcomes. Acta Paediatr. Suppl. 2002, 91, 12-15.
108. Klebanoff, M.A.; Carey, J.C.; Hauth, J.C.; Hillier, S.L.; Nugent, R.P.; Thom, E.A.; Ernest, J.M.; Heine, R.P.; Wapner, R.J.; Trout, W.; et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N. Engl. J. Med. 2001, 345, 487-493.
109. ACOG Practice Bulletin. Vaginitis. Obstet. Gynecol. 2006, 107, 1195-1206.
110. Sobel, J.D. Vaginitis. N. Engl. J. Med. 1997, 337, 1896-1903.
111. Nyirjesy, P.; Sobel, J.D. Advances in diagnosing vaginitis: Development of a new algorithm. Curr. Infect. Dis. Rep. 2005, 7, 458-462.
112. Latini Keller, V.; Junod Perron, N.; Graf, J.D.; Stoermann Chopard, C. Urinalysis: What a primary care physician needs to know. Rev. Med. Suisse 2009, 5, 1870-1875.
113. Tita, A.T.; Andrews, W.W. Diagnosis and management of clinical chorioamnionitis. Clin. Perinatol. 2010, 37, 339-354.
114. Gonen, R.; Korobochka, R.; Degani, S.; Gaitini, L. Association between epidural analgesia and intrapartum fever. Amer. J. Perinatol. 2000, 17, 127-130.
115. Maayan-Metzger, A.; Mazkereth, R.; Shani, A.; Kuint, J. Risk factors for maternal intrapartum fever and short-term neonatal outcome. Fetal Pediatr. Pathol. 2006, 25, 169-177.
116. Lieberman, E.; Lang, J.M.; Frigoletto, F., Jr.; Richardson, D.K.; Ringer, S.A.; Cohen, A. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics 1997, 99, 415-419.
117. Cabbad, M.; Sijin, O.; Minkoff, H. Short course of antibiotics for post-cesarean section endometritis. Amer. J. Obstet. Gynecol. 1987, 157, 908-909.
118. Edwards, R.K.; Duff, P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet. Gynecol. 2003, 102, 957-961.
119. Chapman, S.J.; Owen, J. Randomized trial of single-dose vs. multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis. Amer. J. Obstet. Gynecol. 1997, 177, 831-834.